| 1 |
32223238 | Multistep Binding of the Non-Steroidal Inhibitors Orteronel and Seviteronel to Human Cytochrome P450 17A1 and Relevance to Inhibition of Enzyme Activity. | 2020 Jun 25 |
1 |
| 2 |
33004739 | CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials. | 2020 Sep |
1 |
| 3 |
28373265 | Structural and Functional Evaluation of Clinically Relevant Inhibitors of Steroidogenic Cytochrome P450 17A1. | 2017 Jun |
1 |
| 4 |
26971992 | Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials. | 2016 May |
1 |
| 5 |
25560485 | CYP17A1 inhibitors in castration-resistant prostate cancer. | 2015 Mar |
1 |
| 6 |
24799061 | Orteronel for the treatment of prostate cancer. | 2014 Apr |
1 |
| 7 |
23371447 | Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor. | 2013 Apr |
2 |
| 8 |
23856460 | Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys. | 2013 Nov |
2 |
| 9 |
24314737 | [Prostate cancer and new hormonal treatments: mechanism of action and main clinical results]. | 2013 Oct |
1 |
| 10 |
22249003 | Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys. | 2012 Apr |
3 |